Trend in approval of targeted biologics in the last two decades
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
Auteur principal: | Siddika, Khadiza |
---|---|
Autres auteurs: | Ahmed, Syeda Maliha |
Format: | Thèse |
Langue: | English |
Publié: |
Brac University
2024
|
Sujets: | |
Accès en ligne: | http://hdl.handle.net/10361/24296 |
Documents similaires
-
Targeted therapeutic options in the treatment of Breast Cancer
par: Alam, Kazi Tasnuva
Publié: (2022) -
Study on anticancer drugs approved by the FDA from 2014 to 2023
par: Rattry, Faria Rahman
Publié: (2024) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
par: Tania, Umme
Publié: (2023) -
RIPK pathway, as a potential target, for cancer treatment - a review
par: Jahan, Nusrat
Publié: (2024) -
Molecular biology : genes to proteins /
par: Tropp, Burton E.
Publié: (2008)